Metformin reduces PD-L1 on tumor cells and enhances the anti-tumor immune response generated by vaccine immunotherapy is a research paper published in Journal for ImmunoTherapy of Cancer (2021). On theSindex it has a DataRank of 0.635. It has been cited 68 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.635
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NCI/NIH
Grant: R01 CA202763
NCI/NIH
Grant: R01 CA202763-S
NCI/NIH
Grant: R01 CA208328-01A1
NCI NIH HHS
Grant: R01 CA208328
National Institutes of Health
Grant: 3R01CA202763-04S1
Membrane-based immunotherapy for triple negative breast cancer- a partnered approach
FWCI
3.55
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals